Company / Cash per Share
IRONWOOD PHARMACEUTICALS INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.34
FY2025
5-year range
$0.57 / $3.86
FY2021-FY2025
Trend
+137.4%
vs FY2024
Sector context
#133 of 205
Health Care
What the data says
At $1.34, IRONWOOD PHARMACEUTICALS INC's cash per share ranks #133 of 205 in the Health Care sector. Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $1.34.
Based on SEC 10-K filings.
1.34 in FY2025 with a 5-year CAGR of +3.7%.
Improved from $0.60 to $1.34 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -29.4%
- 5-Year CAGR
- +3.7%
- 10-Year CAGR
- -
Sector benchmark
#133 of 205 in Health CareTop 65% of 205This company $1.34 Sector average $67.98
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 137.4% year-over-year.
- Ranks #133 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.34 | +137.4% |
| FY2024 | $0.57 | -5.3% |
| FY2023 | $0.60 | -84.4% |
| FY2022 | $3.83 | -0.9% |
| FY2021 | $3.86 | +243.6% |
| FY2020 | $1.12 | -2.0% |
| FY2019 | $1.15 | +32.1% |
| FY2018 | $0.87 | -1.9% |
| FY2017 | $0.88 | +124.1% |
| FY2016 | $0.39 | -82.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026